AngioDynamics grants CEO Eric Honroth 101,193 restricted stock units

ANGO•2026-11-04

AngioDynamics granted President and CEO Eric Honroth 101,193 shares of common stock and 62,928 performance rights covering the same number of shares on November 2, 2026.

1. Equity awards

AngioDynamics granted President and CEO Eric Honroth 101,193 shares of common stock on November 2, 2026. Honroth also received 62,928 performance rights covering 62,928 shares of common stock that day.

Sources

AngioDynamics grants CEO Eric Honroth 101,193 restricted stock units

Sec

AngioDynamics grants CEO Eric Honroth 101,193 restricted stock units

1. Equity awards

Related News

Qualcomm shares slide as smartphone weakness clouds growth push

Bio Green Med Solution receives Nasdaq notice over minimum bid price violation

Jazz Pharmaceuticals director Bruce C. Cozadd sells $1.3 million in common shares

Sources

AngioDynamics grants CEO Eric Honroth 101,193 restricted stock units

Samsara EVP and CFO Dominic Phillips reports sale of $1.23 million in common shares

White House sets hearing on Fed's Cook for December 14, reportedly